Prevail Therapeutics
Clinical trials sponsored by Prevail Therapeutics, explained in plain language.
-
One-Time gene shot could free gaucher patients from lifelong infusions
Disease control Recruiting nowThis early-stage trial tests a single-dose gene therapy (LY3884961) for adults with Gaucher disease type 1. The goal is to see if it is safe and can reduce or stop the need for regular enzyme replacement therapy. About 15 participants will receive one intravenous dose and be foll…
Phase: PHASE1, PHASE2 • Sponsor: Prevail Therapeutics • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
New Parkinson's drug enters early human safety trials
Disease control Recruiting nowThis early-stage study tests an experimental drug called LY3962681 in healthy volunteers and people with Parkinson's disease. The main goal is to check safety and how the body processes the drug. Participants receive one or two injections into the spinal fluid and are followed fo…
Phase: PHASE1 • Sponsor: Prevail Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:04 UTC